GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (BUE:ABBV) » Definitions » Purchase Of Business

AbbVie (BUE:ABBV) Purchase Of Business : ARS-11,210,951 Mil (TTM As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is AbbVie Purchase Of Business?

AbbVie's purchase of business for the three months ended in Mar. 2025 was ARS-573,528 Mil. It means AbbVie spent ARS573,528 Mil on purchasing business. AbbVie's purchase of business for the trailing twelve months (TTM) ended in Mar. 2025 was ARS-11,210,951 Mil.

Compared with last quarter (ARS-1,809,920 Mil in Dec. 2024 ), AbbVie spent less money on purchasing business in Mar. 2025 (ARS-573,528 Mil).

AbbVie Purchase Of Business Historical Data

The historical data trend for AbbVie's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbbVie Purchase Of Business Chart

AbbVie Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Purchase Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3,223,461.68 -192,082.98 -133,114.10 -441,503.00 -20,722,170.21

AbbVie Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Purchase Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7,910,232.63 -754,906.49 -8,072,596.15 -1,809,920.02 -573,527.87

AbbVie Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ARS-11,210,951 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AbbVie Purchase Of Business Related Terms

Thank you for viewing the detailed overview of AbbVie's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

AbbVie Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (BUE:ABBV) » Definitions » Purchase Of Business
Comparable Companies
JNJ MRK AMGN PFE GILD BMY BIIB OGN AMRN MDCX LLY OCSE:NOVO B XSWX:ROG XSWX:NOVN LSE:AZN XPAR:SAN TSE:4519 LSE:GSK TSE:4568 SHSE:600276
Traded in Other Exchanges
ABBV:USA ABBV:Mexico 1ABBV:Italy 0QCV:UK 4AB:Germany ABBVCL:Chile ABBV:Canada ABBV34:Brazil 4AB:Bulgaria ABBV:Austria
Address
1 North Waukegan Road, North Chicago, IL, USA, 60064-6400
Website
https://www.abbvie.com
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).